UK markets closed

ZIOPHARM Oncology, Inc. (WEK.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
1.41000.0000 (0.00%)
As of 08:10AM CEST. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

Currency in USD. All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
5
5
2,922
398
0
Operating expenses
Research development
16,279
16,279
25,018
49,643
52,696
Selling general and administrative
12,219
12,219
13,142
27,564
27,665
Total operating expenses
28,498
28,498
38,160
77,207
80,361
Operating income or loss
-28,493
-28,493
-35,238
-76,809
-80,361
Interest expense
1,921
1,921
3,154
1,189
0
Total other income/expenses net
-4,726
-4,726
662
-753
385
Income before tax
-35,140
-35,140
-37,730
-78,751
-79,976
Income from continuing operations
-35,140
-35,140
-37,730
-78,751
-79,976
Net income
-35,140
-35,140
-37,730
-78,751
-79,976
Net income available to common shareholders
-35,140
-35,140
-37,730
-78,751
-79,976
Basic EPS
-
-
-
-
-0.38
Diluted EPS
-
-
-
-
-0.38
Basic average shares
-
-
-
-
209,636
Diluted average shares
-
-
-
-
209,636